pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›menotropins
drug · protein
save

menotropins

Phase 3updated 3mo ago
by Granata Bio Inc🔗 ChEMBL
Phase 3
community read0 votes

Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for female infertility and 3 investigational indications.

targets

Follicle-stimulating hormone receptorLutropin-choriogonadotropic hormone receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

trade names
Gynogen hp, Humegon, Humog, Menopur, Merional, Normegon
generic
menotropins
MOA
Follicle stimulating hormone receptor agonist; Luteinizing hormone/Choriogonadotropin receptor agonist
indication
Female Infertility
phase
phase_3
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 21m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?